J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment…
ADCs continue to be the hot topic in big pharma. Prior to the announced J&J deal, last year alone saw 155 deals struck for the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
J&J
J&J appoints Dr John Reed as EVP, Pharma, R&D
Dr Reed will join J&J on April 3, 2023, assuming responsibility for the company’s portfolio from Dr William Hait, who has…
Indian patent office hears pre-grant patent oppositions on evergreening of bedaquiline patent
Applicants will now be given a chance to respond
US FDA amends J&J vaccine fact sheet to include rare bleeding risk
The amendment fact sheet follows similar moves for the vaccine by other regulators, including that of the European Medicines…
WHO might give nod for Covaxin this month
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s…
FDA, CDC calling to halt distribution of J&J vaccine is a blow to global vaccine effort:…
Following the news that the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)…
US halts J&J COVID-19 vaccine after six women under 50 develop rare blood clots
FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing…
QUAD pledges to supply billion doses of COVID-19 vaccine across Asia by 2022
The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change,…
US gives EUA J&J’s COVID-19 vaccine
In J&J’s 44,000-person global trial, the vaccine was found to be 66 per cent effective at preventing moderate-to-severe…
J&J’s COVID-19 vaccine best used to curb outbreak, Novavax’s vaccine for overall…
As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth,…